Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | UGT2B7 | P16662 | 2/20 | 0.35 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38049 | 1.00 | HTT (0.43) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL4257649 | 1.00 | HTT (0.43) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL17263955 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL1151110 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL221714 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL23749603 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL9743609 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL4599663 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL15290579 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR | |
| SCHEMBL9063561 | 0.97 | HTT (0.47) | HTTSMN1; SMN2NPC1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 838 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-05-14 | — | — | US | claimed |
| US-12595368-B2 | UV/HEVL-filtering contact lenses | ALCON INC. (CH) | 2026-04-07 | — | — | US | claimed |
| EP-3642276-B1 | POLYVINYL CHLORIDE COMPOSITIONS CONTAINING IMPACT MODIFIERS AND CALCIUM CARBONATE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-25 | — | — | EP | claimed |
| US-12570784-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-03-10 | — | — | US | claimed |
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-02-03 | — | — | US | claimed |
| EP-3994219-B1 | A COATING COMPOSITION, ITS PREPARATION METHOD AND USE THEREOF | BASF COATINGS GMBH (DE) | 2025-10-08 | — | — | EP | claimed |
| EP-4529621-A1 | UV/HEVL-FILTERING CONTACT LENSES | Alcon Inc. (CH) | 2025-04-02 | — | — | EP | claimed |
| EP-4514597-A1 | METHOD FOR MAKING UV AND HEVL-ABSORBING OPHTHALMIC LENSES | Alcon Inc. (CH) | 2025-03-05 | — | — | EP | claimed |
| EP-3847220-B1 | UV-CURABLE HOT MELT ADHESIVE COMPOSITIONS FOR FLOORING APPLICATIONS | BASF SE (DE) | 2025-03-05 | — | — | EP | claimed |
| EP-4514595-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2025-03-05 | — | — | EP | claimed |
| EP-3177784-A1 | CUSHION FLOORING MATERIAL AND MANUFACTURING METHOD FOR THE SAME | LG Hausys, Ltd. (KR) | 2017-06-14 | — | — | EP | claimed |
| EP-2299328-B1 | Coated carriers | XEROX CORP (US) | 2017-04-19 | — | — | EP | claimed |
| EP-2299327-B1 | Coated carriers | XEROX CORP (US) | 2017-03-01 | — | — | EP | claimed |
| WO-2016043453-A1 | CUSHION FLOORING MATERIAL AND MANUFACTURING METHOD FOR THE SAME | LG HAUSYS, LTD. (KR) | 2016-03-24 | — | — | WO | claimed |
| EP-2173791-B1 | WATER-BASED DISPERSIONS OF HIGHLY-BRANCHED POLYMERS | BASF CORP (US) | 2014-06-18 | — | — | EP | claimed |
| EP-2231777-B1 | CHEMICAL AND IMPACT RESISTANT THERMOPLASTIC RESIN COMPOSITION HAVING IMPROVED EXTRUDABILITY. | CHEIL IND INC (KR) | 2014-04-30 | — | — | EP | claimed |
| EP-2456792-B1 | PROCESS FOR THE PRODUCTION OF CONDENSATION POLYMERS VIA IN-REACTOR CHAIN EXTENSION AND PRODUCTS THEREOF | BASF CORP (US) | 2014-03-12 | — | — | EP | claimed |
| EP-1203029-B1 | PROCESS FOR THE CONTINUOUS PRODUCTION OF GEL FREE POLYMERS, AND POWDER AND LIQUID COATING APPLICATIONS CONTAINING GEL FREE POLYMERS | JOHNSON POLYMER INC (US) | 2004-11-10 | — | — | EP | claimed |
| EP-0590573-B1 | Resin for plastic lens | HITACHI CHEMICAL CO LTD (JP) | 1998-01-07 | — | — | EP | claimed |
| EP-0067308-B1 | NEUTRALIZING LAYER FOR COLOR TRANSFER ASSEMBLAGES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-03-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | INF2, CRYZ, CRYAA | HTT 2427/4885SMN1; SMN2 4286/4885NPC1 4717/4885 |
| US-12595368-B2 | UV/HEVL-filtering contact lenses | UACA, HSPA4L, RAD54L | HTT 27/4885SMN1; SMN2 4624/4885NPC1 3998/4885 |
| US-12570784-B2 | Method for making embedded hydrogel contact lenses | CRYAB, CRYZ, CRYAA | HTT 3111/4885SMN1; SMN2 4766/4885NPC1 3173/4885 |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | CRYZ, CRYAB, CRYAA | HTT 1364/4885SMN1; SMN2 4239/4885NPC1 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.